Article 29 May 2024 Summary Of LDT Rule: An In-Depth Look At The Final Rule Regarding Laboratory-Developed Tests United States Healthcare
Article 29 May 2024 Will FDA's LDT Final Rule Bring "Balance To The (IVD) Force"? United States Compliance
Article 27 May 2024 The First Biosimilar Disputes At The Unified Patent Court (UPC) United States Healthcare
Article 29 Feb 2024 Chugai, Genentech, And Hoffmann-La Roche Dismiss Appeals Of Actemra® Patent IPR Final Written Decisions United States IP
Article 27 Nov 2023 BPCIA Litigation Related To Proposed Eylea Biosimilar CT-P42 Filed United States IP
Article 18 Oct 2023 Venable's BiologicsHQ Monthly Injection – September 2023 United States Healthcare